Article info

Download PDFPDF
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
  1. Correspondence to:
    Dr Nils Feltelius
    The Swedish Medical Products Agency, PO Box 26, SE-751 03 Uppsala, Sweden; nils.felteliusmpa.se
View Full Text

Citation

Feltelius N, Fored CM, Blomqvist P, et al
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept

Publication history

  • Accepted June 1, 2004
  • First published June 18, 2004.
Online issue publication 
October 25, 2017